Respiratory syncytial virus: Reverse genetics and vaccine strategies

被引：58

作者：

Collins, PL ^{[1
]}

Murphy, BR ^{[1
]}

机构：

[1] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA

来源：

VIROLOGY | 2002年 / 296卷 / 02期

关键词：

D O I：

10.1006/viro.2002.1437

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页码：204 / 211

页数：8

共 58 条

[1] EXPERIMENTAL RESPIRATORY SYNCYTIAL VIRUS-INFECTION OF 4 SPECIES OF PRIMATES [J].

BELSHE, RB ;

RICHARDSON, LS ;

LONDON, WT ;

SLY, DL ;

LORFELD, JH ;

CAMARGO, E ;

PREVAR, DA ;

CHANOCK, RM .

JOURNAL OF MEDICAL VIROLOGY, 1977, 1 (03) :157-162

[2] REVERSE GENETICS - DIRECTED MODIFICATION OF DNA FOR FUNCTIONAL-ANALYSIS - REMARKS [J].

BERG, P .

GENE, 1993, 135 (1-2) :261-264

[3] The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription [J].

Bermingham, A ;

Collins, PL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11259-11264

[4] Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development [J].

Brandenburg, AH ;

Neijens, HJ ;

Osterhaus, ADME .

VACCINE, 2001, 19 (20-22) :2769-2782

[5] Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host range and evaluation as a live-attenuated HRSV vaccine [J].

Buchholz, UJ ;

Granzow, H ;

Schuldt, K ;

Whitehead, SS ;

Murphy, BR ;

Collins, PL .

JOURNAL OF VIROLOGY, 2000, 74 (03) :1187-1199

[6] Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells [J].

Bukreyev, A ;

Belyakov, IM ;

Berzofsky, JA ;

Murphy, BR ;

Collins, PL .

JOURNAL OF VIROLOGY, 2001, 75 (24) :12128-12140

[7] Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides [J].

Cano, F ;

Plotnicky-Gilquin, H ;

Nguyen, TN ;

Liljeqvist, S ;

Samuelson, P ;

Bonnefoy, JY ;

Ståhl, S ;

Robert, A .

VACCINE, 2000, 18 (24) :2743-2752

[8] EVALUATION IN CHIMPANZEES OF VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS [J].

COLLINS, PL ;

PURCELL, RH ;

LONDON, WT ;

LAWRENCE, LA ;

CHANOCK, RM ;

MURPHY, BR .

VACCINE, 1990, 8 (02) :164-168

[9] Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics [J].

Collins, PL ;

Whitehead, SS ;

Bukreyev, A ;

Fearns, R ;

Teng, MN ;

Juhasz, K ;

Chanock, RM ;

Murphy, BR .

ADVANCES IN VIRUS RESEARCH, VOL 54, 1999, 54 :423-451

[10] PRODUCTION OF INFECTIOUS HUMAN RESPIRATORY SYNCYTIAL VIRUS FROM CLONED CDNA CONFIRMS AN ESSENTIAL ROLE FOR THE TRANSCRIPTION ELONGATION-FACTOR FROM THE 5'-PROXIMAL OPEN READING FRAME OF THE M2 MESSENGER-RNA IN GENE-EXPRESSION AND PROVIDES A CAPABILITY FOR VACCINE DEVELOPMENT [J].

COLLINS, PL ;

HILL, MG ;

CAMARGO, E ;

GROSFELD, H ;

CHANOCK, RM ;

MURPHY, BR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11563-11567

← 1 2 3 4 5 6 →